The Future of Neuroregenerative Therapy for Parkinson’s Disease

Publisher： Bentham Science Publishers

E-ISSN： 2211-5439|3|1|25-33

ISSN： 2211-5420

Source： Current Tissue Engineering, Vol.3, Iss.1, 2014-03, pp. : 25-33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Telediagnosis of Parkinson’s Disease Using Measurements of Dysphonia

By Sakar C.   Kursun Olcay  

Journal of Medical Systems, Vol. 34, Iss. 4, 2010-08 ,pp. : 591-599

Springer Publishing Company

Access to resources Recommend Favorite

An Update on Human Stem Cell-Based Therapy in Parkinson#39;s Disease

By  

Current Stem Cell Research & Therapy, Vol. 11, Iss. 7, 2016-08 ,pp. : 561-568

Bentham Science Publishers

Access to resources Recommend Favorite

Mesenchymal Stem Cells as a Source of Dopaminergic Neurons: A Potential Cell Based Therapy for Parkinson#39;s Disease

By  

Current Stem Cell Research & Therapy, Vol. 12, Iss. 4, 2017-04 ,pp. : 326-347

Bentham Science Publishers

Access to resources Recommend Favorite

Protein aggregation in Huntington's and Parkinson's disease: implications for therapy

By Wanker E.E.  

Molecular Medicine Today, Vol. 6, Iss. 10, 2000-10 ,pp. : 387-391

Elsevier

Access to resources Recommend Favorite

Recent Progress in Gene Therapy for Parkinson's Disease

By  

Current Molecular Medicine, Vol. 12, Iss. 10, 2012-12 ,pp. : 1311-1318

Bentham Science Publishers

Access to resources Recommend Favorite